The U.S. Department of Veterans Affairs (VA) is introducing new consent requirements for some psychiatric medications prescribed to younger veterans. Under the new policy, veterans under 30 may be required to sign consent forms before receiving certain antidepressant treatments. The changes are expected to take effect in 2027.
The policy is part of a broader effort to provide additional information and documentation before certain psychiatric medicines are prescribed. Supporters of such consent procedures may view them as a way to ensure that younger patients understand potential benefits and risks before treatment.
However, some medical and mental-health organizations have raised concerns that additional consent requirements could make psychiatric treatment appear more complicated or stigmatized. They have questioned whether the policy could discourage some veterans from seeking help for mental-health concerns.
The new requirements are scheduled to begin in 2027, meaning the VA and healthcare providers have time to prepare for the changes and explain the new procedures to patients.
In short: The VA plans to introduce additional consent requirements for some psychiatric medications prescribed to veterans under 30. The policy is intended to add an extra step before treatment, while medical groups have expressed concerns about its possible effect on access to and perceptions of mental-health care.
